Part two of this webinar series will build upon the foundation presented in Part 1. Come away with the knowledge and skillset you need to utilize best practices when considering autologous and allogeneic products. Cell and gene therapy experts will cover critical quality attributes (CQA), critical product parameter (CPP), and critical material attributes (CMA). If your role focuses on cell therapy control strategy, don’t miss out on this specialized webinar.
This webinar is presented as part of the 2020 PDA Advanced Therapy Medicinal Products Month webinar series.